Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy
Barbara Montico(Centro di Riferimento Oncologico), Elisabetta Fratta(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 24
Related Papers
Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development
|International Journal of Molecular Sciences|2018|124